IFNA1 and COVID-19: Given their responsiveness to IFN signaling, ISG15 and its downstream targets, including MX1156, have been implicated as key participants during SARS-CoV-2 infection by using in vitro and in vivo models157–159 as well as samples from COVID-19 patients160–162.